These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 38995156)
1. Proteomic and phosphoproteomic profiling of urinary small extracellular vesicles in hepatocellular carcinoma. Li D; Gao Y; Wang C; Hu L Analyst; 2024 Aug; 149(17):4378-4387. PubMed ID: 38995156 [TBL] [Abstract][Full Text] [Related]
2. Proteomic analysis of small extracellular vesicles from the plasma of patients with hepatocellular carcinoma. Dong W; Xia Z; Chai Z; Qiu Z; Wang X; Yang Z; Wang J; Zhang T; Zhang Q; Jin J World J Surg Oncol; 2022 Dec; 20(1):387. PubMed ID: 36471393 [TBL] [Abstract][Full Text] [Related]
3. A facile "one-material" strategy for tandem enrichment of small extracellular vesicles phosphoproteome. Jiao F; Gao F; Liu Y; Fan Z; Xiang X; Xia C; Lv Y; Xie Y; Bai H; Zhang W; Qin W; Qian X Talanta; 2021 Feb; 223(Pt 2):121776. PubMed ID: 33298282 [TBL] [Abstract][Full Text] [Related]
4. Integrated proteomic, phosphoproteomic, and N-glycoproteomic analyses of small extracellular vesicles from C2C12 myoblasts identify specific PTM patterns in ligand-receptor interactions. Chen X; Song X; Li J; Wang J; Yan Y; Yang F Cell Commun Signal; 2024 May; 22(1):273. PubMed ID: 38755675 [TBL] [Abstract][Full Text] [Related]
5. Discovery of candidate biomarkers from plasma-derived extracellular vesicles of patients with cirrhosis and hepatocellular carcinoma: an exploratory proteomic study. Zertuche-Martínez C; Velázquez-Enríquez JM; González-García K; Santos-Álvarez JC; Romero-Tlalolini MLÁ; Pina-Canseco S; Pérez-Campos Mayoral L; Muriel P; Villa-Treviño S; Baltiérrez-Hoyos R; Arellanes-Robledo J; Vásquez-Garzón VR Mol Omics; 2024 Aug; 20(7):483-495. PubMed ID: 39011654 [TBL] [Abstract][Full Text] [Related]
6. Small Extracellular Vesicle-Derived vWF Induces a Positive Feedback Loop between Tumor and Endothelial Cells to Promote Angiogenesis and Metastasis in Hepatocellular Carcinoma. Wong SWK; Tey SK; Mao X; Fung HL; Xiao ZJ; Wong DKH; Mak LY; Yuen MF; Ng IO; Yun JP; Gao Y; Yam JWP Adv Sci (Weinh); 2023 Sep; 10(26):e2302677. PubMed ID: 37387563 [TBL] [Abstract][Full Text] [Related]
7. In Vivo Phosphoproteome Analysis Reveals Kinome Reprogramming in Hepatocellular Carcinoma. Ren L; Li C; Wang Y; Teng Y; Sun H; Xing B; Yang X; Jiang Y; He F Mol Cell Proteomics; 2018 Jun; 17(6):1067-1083. PubMed ID: 29472430 [TBL] [Abstract][Full Text] [Related]
8. Discovery of small extracellular vesicle proteins from human serum for liver cirrhosis and liver cancer. Uzzaman A; Zhang X; Qiao Z; Zhan H; Sohail A; Wahid A; Shang Z; Guan X; Cao CX; Xiao H Biochimie; 2020 Oct; 177():132-141. PubMed ID: 32835735 [TBL] [Abstract][Full Text] [Related]
9. Small extracellular vesicles containing miR-30a-3p attenuate the migration and invasion of hepatocellular carcinoma by targeting SNAP23 gene. Liu C; Zhou X; Long Q; Zeng H; Sun Q; Chen Y; Wu D; Liu L Oncogene; 2021 Jan; 40(2):233-245. PubMed ID: 33110233 [TBL] [Abstract][Full Text] [Related]
10. Proteomics and Phosphoproteomics of Circulating Extracellular Vesicles Provide New Insights into Diabetes Pathobiology. Nunez Lopez YO; Iliuk A; Petrilli AM; Glass C; Casu A; Pratley RE Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628588 [TBL] [Abstract][Full Text] [Related]
11. Roles of small extracellular vesicles in the development, diagnosis and possible treatment strategies for hepatocellular carcinoma (Review). Yang S; Wang J; Wang S; Zhou A; Zhao G; Li P Int J Oncol; 2022 Aug; 61(2):. PubMed ID: 35674180 [TBL] [Abstract][Full Text] [Related]
12. Reveal the molecular signatures of hepatocellular carcinoma with different sizes by iTRAQ based quantitative proteomics. Wang Y; Liu H; Liang D; Huang Y; Zeng Y; Xing X; Xia J; Lin M; Han X; Liao N; Liu X; Liu J J Proteomics; 2017 Jan; 150():230-241. PubMed ID: 27693406 [TBL] [Abstract][Full Text] [Related]
13. Interplay among extracellular vesicles, cancer stemness and immune regulation in driving hepatocellular carcinoma progression. Tsui YM; Tian L; Lu J; Ma H; Ng IO Cancer Lett; 2024 Aug; 597():217084. PubMed ID: 38925362 [TBL] [Abstract][Full Text] [Related]
14. Metabolic self-feeding in HBV-associated hepatocarcinoma centered on feedback between circulation lipids and the cellular MAPK/mTOR axis. Zhu Y; Zhao Y; Ning Z; Deng Y; Li B; Sun Y; Meng Z Cell Commun Signal; 2024 May; 22(1):280. PubMed ID: 38773448 [TBL] [Abstract][Full Text] [Related]
15. Proteomic Analysis of Salivary Extracellular Vesicles from COVID-19 Patients Reveals a Specific Anti-COVID-19 Response Protein Signature. Weber L; Torres A; Realini O; Bendek MJ; Mizgier ML; Brizuela C; Herrera D; González FE; Chaparro A Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612515 [TBL] [Abstract][Full Text] [Related]
16. Characterisation of Colorectal Cancer Cell Lines through Proteomic Profiling of Their Extracellular Vesicles. Heck KA; Lindholm HT; Niederdorfer B; Tsirvouli E; Kuiper M; Flobak Å; Lægreid A; Thommesen L Proteomes; 2023 Jan; 11(1):. PubMed ID: 36648961 [TBL] [Abstract][Full Text] [Related]
17. Targeted inhibition of ACK1 can inhibit the proliferation of hepatocellular carcinoma cells through the PTEN/AKT/mTOR pathway. Wang B; Song K; Chen L; Su H; Gao L; Liu J; Huang A Cell Biochem Funct; 2020 Jul; 38(5):642-650. PubMed ID: 32162707 [TBL] [Abstract][Full Text] [Related]
18. Autophagy inhibition mediated by trillin promotes apoptosis in hepatocellular carcinoma cells via activation of mTOR/STAT3 signaling. Zhan G; Wei T; Xie H; Xie X; Hu J; Tang H; Cheng Y; Liu H; Li S; Yang G Naunyn Schmiedebergs Arch Pharmacol; 2024 Mar; 397(3):1575-1587. PubMed ID: 37676495 [TBL] [Abstract][Full Text] [Related]
19. Whole-transcriptome and proteome analyses identify key differentially expressed mRNAs, miRNAs, lncRNAs and circRNAs associated with HCC. Xu F; Jiang L; Zhao Q; Zhang Z; Liu Y; Yang S; Yu M; Chen H; Zhang J; Zhang J Oncogene; 2021 Jul; 40(29):4820-4831. PubMed ID: 34155346 [TBL] [Abstract][Full Text] [Related]
20. New liver cancer biomarkers: PI3K/AKT/mTOR pathway members and eukaryotic translation initiation factors. Golob-Schwarzl N; Krassnig S; Toeglhofer AM; Park YN; Gogg-Kamerer M; Vierlinger K; Schröder F; Rhee H; Schicho R; Fickert P; Haybaeck J Eur J Cancer; 2017 Sep; 83():56-70. PubMed ID: 28715695 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]